Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1323099 (
sympathomimetic
)
2,957
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Research work on the possible mutagenic effects of the amphetamine,
sympathomimetic
amine, was carried out on the rat. The method used was the dominant lethal assay, in its sub-acute form.
Dextroamphetamine
sulphate was administered orally. At the dosage and frequency of the test, dextroamphetamine sulphate was found to be a significantly mutogenic agent. The over-all mutagenic index was 13.92% (P less than 0.01) for the test group and 8.90% for the control group.
...
PMID:Mutagenicity obtained experimentally by oral administration of dextroamphetamine sulphate to the rat. 26 Aug 96
The effects of different loading procedures on norepinephrine-3H (NE-3H) efflux induced by a structurally analogous group of indirectly acting
sympathomimetic
amines was examined in rabbit vas deferens.
(+)-Amphetamine
was ineffective in releasing 3H from tissues with intact intraneuronal storage granules but was an effective depletor of (a) non-granular intraneuronal compartment(s) following in vivo treatment with reserpine. (+/-)-p-Hydroxynorephedrine was a less effective depletor of non-granular NE-3H. These experiments provide further evidence in support of multiple intraneuronal storage compartments which can be pharmacologically differentiated by utilizing indirectly acting
sympathomimetic
amine agents.
...
PMID:Sympathomimetic amine-induced release of norepinephrine-3H from different intraneuronal storage compartments. 731 41